Navigation Links
Amplify™ Surgical Inc. Reaches Milestone of 300 Levels Treated with dualX® Expanding Interbody Fusion System
Date:3/3/2020

Amplify Surgical, Inc., today announces that the company reached the milestone of treating 300 spinal levels with the dualX Expanding Interbody Fusion System.

The landmark case was performed by Dr. Ali Najafi at Fresno Heart and Surgical Hospital in Fresno, CA. After the case Dr. Najafi noted, “dualX has completely changed the game for expandable interbodies. The ability to achieve an ALIF sized footprint from a posterior approach while maximizing height expansion is unparalleled on the market. Before dualX we have been limited to much smaller footprints when using expandable technology, now with dualX we have the best of both worlds.”

The dualX technology is comprised of a family of titanium expandable interbody devices designed to expand in both width and height, implanted in lateral lumbar interbody fusion (LLIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) spinal procedures. The dualX portfolio contains varying footprints, heights and degrees of lordosis with post-expansion bone grafting to provide a customized anatomical fit for a clinically successful fusion environment.

Dr. Jeffrey Roh, CEO of IntuitiveX commented, “It is exciting to see the clinical benefits of the dualX expanding interbody system. As this system gains more exposure it is proving to be the preferred interbody for surgeons seeking innovative solutions.”

Andy Choi, Amplify Surgical CEO stated, “I am so very pleased as we are seeing unprecedented adoption during full commercialization launch. Even since our first cases I have seen such great results and it is exciting to support surgeons with revolutionary technology. We are more than doubling our growth quarter over quarter and we expect continuous improvement as we go further into 2020.”

About Amplify Surgical, Inc.
Amplify Surgical is a privately held spinal device company located in Laguna Hills, CA. The Company focuses on developing and commercializing innovative and minimally invasive technologies for spine surgery. Amplify Surgical is a portfolio company of IntuitiveX, a life science innovation incubator.

Follow Us:
LinkedIn

Contact:
Andy Choi, CEO
Amplify Surgical, Inc.
info@amplifysurgical.com
765-AMPLIFY

Read the full story at https://www.prweb.com/releases/amplify_surgical_inc_reaches_milestone_of_300_levels_treated_with_dualx_expanding_interbody_fusion_system/prweb16951425.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Non-Surgical Procedures are Now Available at a Discount at Strax Rejuvenation
2. National Robotics Initiative grant to create smarter surgical robots
3. Silk-based surgical implants could offer a better way to repair broken bones
4. Clemson researcher touts surgical safety checklist to save lives
5. New gel to promote bone growth on implants used in surgical procedures
6. Guidepoint Launches Post-Surgical Pain Management TRACKER
7. SF Bay Cosmetic Body Sculpting Introduces A Safe And Non-Surgical Butt Lift With Innovative New Technology, Emsculpt®
8. Surgical Theater Brings Familial Patient Engagement to the Annual Joint AANS/CNS Section on Pediatric Neurosurgery
9. Medacta Recognized for Orthopaedics and Surgical Innovation in 2019 MedTech Breakthrough Awards Program
10. Innovative Surgical Robotics Technologies for Spine Surgery to Become the Standard, Not the Exception
11. Study: Black carbon is ancient by the time it reaches seafloor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... 2020 , ... Flagship Biosciences, providers of expert tissue data ... as Vice President Clinical Diagnostics. Geoff brings 25 years of experience in developing ... lead the creation and implementation of diagnostic tissue tests utilizing Flagship’s unique tissue ...
(Date:3/27/2020)... ... March 24, 2020 , ... PathSensors Inc, a Baltimore biotechnology ... the Novel SARS Coronavirus (SARS-CoV-2), the causal agent for the coronavirus disease COVID–19. ... data on the new SARS-CoV-2 product will be available June 2020. , CANARY ...
(Date:3/20/2020)... ... March 20, 2020 , ... OUHSC and Pure MHC have launched a ... The scientific team is led by William Hildebrand, Ph.D., whose expertise is helping the ... Pure MHC, part of a family of biotechnology companies formed, funded and managed by ...
Breaking Biology News(10 mins):
(Date:3/12/2020)... ... March 12, 2020 , ... With the beginning of ... the business investment in Europe by inaugurating a new scientific facility for academic ... the new Nanoscience Center Europe took place Tuesday, February 18, 2020, gathering customers, ...
(Date:3/4/2020)... ... , ... This month, Cognosante will make its annual appearance at the HIMSS ... and emerging offerings that align with the HIMSS annual theme, “Be the Change.” ... and engaging. From Interoperability and HIE to Cloud Computing ...
(Date:2/26/2020)... ... 2020 , ... Continuing its leading research on human milk ... safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) HMO. , 3-FL is ... are indigestible and therefore function as a prebiotic by promoting early microbial colonization ...
(Date:2/21/2020)... ... 2020 , ... Pharmaceutical manufacturers are under increasing pressure to ... new approaches like ‘Industry 4.0’ and continuous manufacturing, combat the growing and intense ... But with an industry with the world’s tightest regulations and complex value chains, ...
Breaking Biology Technology: